aerocef 200 mg - filmtabletten
astellas pharma gmbh - cefixim - cefixim
suprax saft
astellas pharma gmbh (8083037) - cefixim 3 h<2>o - trockensubstanz - cefixim 3 h<2>o (24412) 111,9 milligramm
tamsulosine hydrochloride yamanouchi pharma 0.4 mg (pi pharma) hard caps. modif.-rel.
tamsulosine hydrochloride yamanouchi pharma 0.4 mg (pi pharma) gél. lib. modif.
tamsulosine hydrochloride yamanouchi pharma 0.4 mg (pi pharma) harde caps. geregul. afgifte
gevilon 600mg
pfizer pharma gmbh (8075658) - gemfibrozil - filmtablette - teil 1 - filmtablette; gemfibrozil (21894) 600 milligramm
vesisol 10 mg - filmtabletten
g.l. pharma gmbh - solifenacin succinat -
vesisol 5 mg - filmtabletten
g.l. pharma gmbh - solifenacin succinat -
probenecid weimer
biokanol pharma gmbh - geschäftsanschrift - (8019393) - probenecid - tablette - probenecid (05841) 500 milligramm
padcev
astellas pharma europe b.v. - enfortumab vedotin - carcinoma, transitional cell; urologic neoplasms - antineoplastische mittel - padcev as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic urothelial cancer who have previously received a platinum-containing chemotherapy and a programmed death receptor 1 or programmed death ligand 1 inhibitor.